Quality of Life in Pediatric VAD- How are we doing? INTERMACS Eighth Annual Meeting May 5, 2014 Karen Uzark, PhD, CPNP University of Michigan Congenital.

Slides:



Advertisements
Similar presentations
Transitional care in the med-peds clinic
Advertisements

CHILD HEALTH NURSING.
Pediatric Chronic Pain and Differences in Parental Health-Related Quality of Life Gustavo R. Medrano¹, Susan T. Heinze¹, Keri R. Hainsworth 2,3, Steven.
Needs assessment of cancer survivors O Santin, L Murray, A Gavin and M Donnelly Cancer health services research and survivorship studies programme Centre.
Associations between Obesity and Depression by Race/Ethnicity and Education among Women: Results from the National Health and Nutrition Examination Survey,
Can Comparative Effectiveness Study Tell Us What Is The Best Therapy For Class IV Heart Failure? Beta blockers or LVADs?
Estimating Benefit in Ambulatory Heart Failure Patients MedaMACS Progress Report 2014 Garrick C. Stewart, MD Brigham and Women’s Hospital.
Donor Utilization: Making Use of a Precious Resource in Cardiac Transplant Jason W. Smith, MD Assistant Professor of Surgery The University of Washington.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September-October 2007.
Data Issues: Quality and Analysis By Ziyad Mahfoud, Ph.D. Associate Professor of Biostatistics Department of Public Health Ziyad Mahfoud, Ph.D.1.
ACHD Patients Should Receive Treatment in Adult Institutions Society of Thoracic Surgeons Adult Cardiac Surgery Database reports 39,872 adults undergoing.
A Survey of Quality of Life Following Surgery for Malignant Pleural Mesothelioma: Reflects the patients’ commitment to Learning about the Disease D A Raffle,
Heart Transplantation for Patients with a Fontan Procedure
A Mission to Save More Lives Where we’ve been, where we are, and where we need to be Thomas A. Nakagawa, M.D, FAAP, FCCM Professor, Anesthesiology and.
What have we learned? What is next? Panel B: Functional Capacity, Quality of Life and Outcomes H.Functional Capacity I.Neurocognitive Assessment J.Quality.
Rivka Herman 1 *,RN. M.Sc Michal Libergal 1 *, PhD; David Rott 2, MD Michal Libergal 1 *, PhD; David Rott 2, MD 1 Henrietta Szold Hadassah-Hebrew University.
1 Hearing the Voices of the Children Measuring Pediatric Health-Related Quality of Life from the Perspective of the Children and Their Parents Quantifying.
Introduction to Ventricular Assist Device (VAD)
Joseph G. Rogers, MD Professor of Medicine Duke University
Predicting Patients at Risk for Poor Global Outcomes after DT- MCS Therapy Suzanne V. Arnold, MD, MHA Saint Luke’s Mid America Heart Institute/UMKC May.
Periportal Fibrosis Without Cirrhosis Does Not Affect Outcomes Following Continuous Flow Ventricular Assist Device Implantation Jonathon E. Sargent, BS,
Presentations: Quantifying the impact of adverse events on HRQOL early after implant Patient selection and estimation of prognosis using health status.
Predicting Major Outcomes after MCSD Implant 1 Risk Factors for Death, Transplant, and Recovery James Kirklin, MD David Naftel, PhD.
Neonates (children less than one month of age) have immature immune systems and are at higher risk for serious complications of bacterial and viral infections,
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients Assessment.
Association of Health Plan’s HEDIS Performance with Outcomes of Enrollees with Diabetes Sarah Hudson Scholle, MPH, DrPH April 9, 2008.
HeartWare HVAD: Risk Factors for Adverse Outcomes Mark S. Slaughter, MD Professor and Chair Department Cardiovascular and Thoracic Surgery University of.
MCS in Special Populations: The Use of Mechanical Support in Adults with Congenital Heart Disease 9 th Annual Meeting May 15, 2015 Christina VanderPluym,MD.
Old, Sick and Alone ? Living arrangements, health and well- being among older people RGS-IBG Annual International Conference London, 2006 Harriet Young.
#1 STATISTICS 542 Intro to Clinical Trials Quality of Life Assessment.
D Ehrmann Feldman, B Swaine, J Gosselin, G Meshefedjian, L Grilli
Meredith Cook – PharmD Candidate Mercer University COPHS August, 2012 Cognitive Trajectories after Postoperative Delirium.
1 Medical Home for Children in Washington State Washington State Data from the 2003 National Survey of Children’s Health Teresa Vollan MCH Assessment Washington.
Registry Data Collection in Pediatric VADs: Challenges and Opportunities INTERMACS Eighth Annual Meeting May 5, 2014 David Rosenthal, MD Stanford Children’s.
Al wakeel J, Bayoumi M, Al Ghonaim M, Al Harbi A, Al Swaida A, Mashraqy A.
Education War Era Cardiac Surgery Health-Related Quality of Life (HRQOL) in Adult Survivors after the Fontan Operations James K. Kirklin, MD Manisha Kukreja,
Assessing Children For Cochlear Implants Assessing Children For Cochlear Implants James H. Johnson, Ph.D. Department of Clinical and Health Psychology.
Development of a novel predictive model for mortality post continuous flow LVAD implant using Bayesian Networks (BN) N. A. Loghmanpour 1, M. K. Kanwar.
INTERMACS: June 2006 – December 2012: CMS Report Adults: n=7849 All primary implants as of 12/31/2012 n= 7928 Pediatric patients: n=79 (patients < 19 yrs.
Pediatric Mechanical Circulatory Support (MCS) Ivan Wilmot, MD Heart Failure, Transplant, MCS Assistant Professor The Heart Institute Cincinnati Children’s.
Predictors of Asthma in Young Children Does Reporting Source Affect Our Conclusions? Jane E. Miller Jane E. Miller, Ph.D. Institute for Health, Health.
Clinical Review AbioCor® Implantable Replacement Heart H Julie Swain M.D. Cardiovascular Surgeon Ileana Piña M.D. Heart Failure Cardiologist DRAFT.
Parent Beliefs Regarding Acceptability of Recruitment Methods in Pediatric Research Susan T. Heinze, M.S., Amy J. Majewski, B.A., Elaine C. Bennaton, B.A.,
Measuring Family HRQOL Spillover Effects Using QALYs Lisa A. Prosser, PhD University of Michigan CANS Special Topics Conference October 14, 2015.
Quality of life in patients with implantable cardioverter defibrillators Author: Camelia Tănăsuc Coordinator: Professor Doctor Dan Dobreanu Coauthors:
The Placement of Atrial Pacing Leads in Patients after Cardiac Surgery
Advanced Therapies Lee R. Goldberg, MD, MPH Medical Director, Heart Failure and Cardiac Transplant Program University of Pennsylvania.
Whose Life is it Anyway? Proxy v. Self reported quality of life in Childhood Cancer Survivors Penney Upton.
Mechanical Circulatory Support in Special Populations Renzo Y. Loyaga-Rendon MD.,PhD.. Assistant Professor Advanced Heart Failure Section University of.
Determinants of Subjective Memory Complaints in Community-dwelling Adults with Traumatic Brain Injury Esther Bay, PhD; Bruno Giordani, PhD; Claire Kalpakjian,
Analysis of Pump Thrombosis in the Intermacs Database Michael Acker William Measey Professor of Surgery Chief of Division of Cardiovascular Surgery Director.
Dyadic Patterns of Parental Perceptions of Health- Related Quality of Life Gustavo R. Medrano & W. Hobart Davies University of Wisconsin-Milwaukee Pediatric.
Module 9 Recording and reporting culture results Exercise 1.
以多重死因資料比較台灣美國腦中風 併發吸入性肺炎之趨勢 奇美醫學中心 張嘉祐醫師. Stroke Statistics -- A Report From the American Heart Association Approximately 56% of stroke deaths in 2009.
Advancing Knowledge to Improve Health Evaluation of the Effects of Complex Care Management on Health-Related Quality of Life within a Medicaid Population.
Transition of Care: When, Why and How? But My Patient Is an Adult:
James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L
Annual Fall Meeting November 13, 2016
Figure 1 Patients outside of target international normalized ratio range by time point and management strategy. All values are expressed as percentages.
Pediatric Psychology: An Overview
Living with the Risk of Sudden Death: Psychology of Mortality
Heart Failure/Late Problems: End of Life Care: Psychology
More Than Survival: Futility
Emma J. Birks, FRCP, PhD, Robert S
Improvement in Survival After Mechanical Circulatory Support With Pneumatic Pulsatile Ventricular Assist Devices in Pediatric Patients  Roland Hetzer,
Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation?  James K. Kirklin, MD, David C. Naftel,
Transitions The wellbeing of young people is at the heart of the transition process.
Long-term follow-up of pediatric cardiac patients requiring mechanical circulatory support  Andra E Ibrahim, MD, Brian W Duncan, MD, Elizabeth D Blume,
Survival of subjects listed for heart transplantation with and without spirometry. Survival of subjects listed for heart transplantation with and without.
Presentation transcript:

Quality of Life in Pediatric VAD- How are we doing? INTERMACS Eighth Annual Meeting May 5, 2014 Karen Uzark, PhD, CPNP University of Michigan Congenital Heart Center

Definitions HEALTH = “not only the absence of disease and infirmity, but the presence of physical, mental, and social well-being” QUALITY OF LIFE = “the individual’s perception of their position in life, in the context of culture and value systems in which they live and in relation to their goals, expectations, standards and concerns” Quality of Life ≠ Physical Health Status or Abilities Quality of life cannot be simply inferred from clinical and laboratory findings or objective criteria WHO 1991 WHO

Dimensions of Quality of Life Physical functioning (Disease state and physical symptoms) Psychological/Emotional functioning Social functioning School/role functioning (Neurodevelopmental functioning)

Ventricular Assist Devices –Goals: Survival to Transplant or Recovery Improved cardiac output → improvement in end-organ function Physical rehabilitation Extubation Mobilization/Ambulation Enteral nutrition Neurological evaluation-rehabilitation → Improved psychosocial quality of life

Quality of Life (QOL) in Children Bridged to Transplant with VADs No significant difference in QOL between 21 children who had VAD and 42 without VAD at a median of 4.2 years post-transplant (Ezon et al, J Thorac Cardiovasc Surg 2014) Limitations: small sample size, wide age range, parent survey only, type of VAD support varied, survivor bias Children who required VAD/ECMO (n=26) reported QOL similar to children without MCS (n=58) at a median of 3 years post transplant * (Wray et al, J Heart Lung Transplant 2012) Limitations: small sample size, wide age range, CHD dx exclusion, type of support varied, parent survey in younger patients, survivor bias * Longer period of heart failure in MCS was associated with poorer child ratings of social QOL.

Experience of Children with VAD as Bridge to Transplant* Qualitative study with semi-structured interviews with children (n=4) over 13 years old. Child responses : Frightened, scared of clots and strokes, appreciative/relieved (would die without it) Not prepared for “big washing machine”, big hoses. *Gilmore and Newall, Pediatr Cardiol 2011.

PediMACS QOL indicators

PedsQL

VAD-specific QOL

Peds QL and VAD Qol Completion Status for Parents/Children by Patient Age N PedsQL - ChildPedsQL - ParentPedsOL - either Completed% % % Age at Follow-Up (24)N/A 00.0%0 <2 years 2-4 years 11N/A 19.1%1 5-7 years 900.0%111% years %723% years 38616%1026%1026% TOTAL 1138/78(10%)1917%19 17%* Pre-Implant *21% excluding <2 years

Peds QL and VAD Qol Completion Status for Parents/Children by Patient Age 3 month Follow-up N Peds QL - ChildPedsQL - ParentPedsQL - eitherVAD QOL - ChildVAD QOL - ParentVAD QOL - either Complete% % % % % % Age at Follow-Up (9)N/A 00.0% %1 <2 years 2-4 years 4N/A 125%1 00.0%125%1 5-7 years 300.0% years 10220% %220% years 20735%525%735% 4 20% 3 15%420% 19+ years 200.0% TOTAL 489/30(30%)_817%10 21% 613%6 8 17%* *21% excluding <2 years

Peds QL – Reasons For Incompletion Reasons for Peds QoL Incompletion ParentChild N%N% Too Sick Urgent Implant, No Time Coordinator Too Busy or Forgot Unable to Contact Patient Other Reason, Specify TOTAL Pre-implant Reasons for Peds QoL Incompletion ParentChild N%N% Too Sick Urgent Implant, No Time Coordinator Too Busy or Forgot Other Reason, Specify TOTAL month Follow-up

OTHER Reasons Form Incomplete Pre-implant (n=43) Forms/IRB not approved -17 (40%) (? license pending -2) Age too young -10; 1 too old (26%) Not consented -12 (28%) Other: Patient autistic -1 No coordinator -2 Post-implant (n=13) Forms/IRB -4 (31%) Age -2 (15%) No Consent -3 (23%) Transplanted -2 (15%) Reason Missing -35

VAD QOL – Parent Report n=4-6

VAD QOL – Parent Report (continued) (n=4-6)

VAD QOL – Child Self-Report (n=6)

VAD QOL – Child Self-Report (continued) (n=6)

VAD QOL – Child Self-Report Differences between 3 and 6 months (n=6 at 3 mos, 5 at 6 mos)

THANK YOU!